Workflow role
MRI acquisition, reconstruction, display, and release-specific workflow support.
exact submission · checked 2026-09-04This is a submission-anchored intended-use summary, not a local acceptance result.
FDA-cleared profile
Esaote, S.p.A.
S-scan Open is an Esaote MR system for diagnostic image acquisition, reconstruction, display, and professional interpretation within the labeled scanner, coil, sequence, and anatomy scope.
Clinical fit
Start with the authorized purpose, then verify how it fits your service line and reading workflow.
Regulatory identity
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Implementation
Use these fields to structure a vendor demo, security review, and implementation estimate.
Exact submission evidence and the current vendor family material do not establish the exact site's DICOM, worklist, PACS/RIS, identity, routing, display, or fallback behavior.
Exact deployment topology, hosting, network boundaries, update mechanism, and local operational requirements are not established for this submission.
Public sources reviewed here do not establish the complete exact-release security posture, including identity, audit, encryption, retention, remote access, vulnerability management, backup, or incident response.
Training, onboarding, competency, and support commitments are commercial implementation details that require current vendor documentation.
Local acceptance testing, production monitoring, drift review, update control, and incident escalation require a current vendor and site-specific governance plan.
MRI acquisition, reconstruction, display, and release-specific workflow support.
exact submission · checked 2026-09-04This is a submission-anchored intended-use summary, not a local acceptance result.
Patient MRI signal data acquired with supported coils, pulse sequences, field strengths, and release-specific protocols.
exact submission · checked 2026-09-04Exact supported inputs and protocol limits must be confirmed from the complete labeling.
Cross-sectional MR images, spectra, derived measurements, and reconstructed series for professional review.
exact submission · checked 2026-09-04Output review, editing, and downstream use remain release- and site-specific.
Current vendor material is product-family context for K260746 only; exact release, enabled options, deployment, and local interoperability require confirmation.
product family · checked 2026-09-04Vendor material is not exact-release evidence unless that linkage is separately proven.
Exact local interfaces, deployment topology, security controls, downtime behavior, and support obligations remain unestablished.
exact submission · checked 2026-09-04Obtain organization-specific implementation evidence before procurement or clinical use.
Evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.
No exact submission and version-linked sensitivity endpoint is published in this dossier; do not substitute a product-family or candidate-study value.
No exact submission and version-linked specificity endpoint is published in this dossier; do not substitute a product-family or candidate-study value.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
Regulatory verification, validation, and labeling evidence reviewed for exact FDA submission K260746. · The labeled population and test materials for exact submission K260746; a general clinical study population is not established here.
exact submission · Tested version: S-scan Open (100001800) (K260746) · Sponsor or vendor studyK260746
FDA regulatory evidence is submission-specific but is not independent clinical performance evidence.
Economics and lifecycle
These are common procurement questions; unknown values remain visible until a source supports them.
No public exact-release price, license fee, subscription, contract, or implementation cost was established in this review.
CMS index context was checked, but no product-specific coverage or reimbursement determination is inferred.
Safety and lifecycle
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Buyer worksheet
Research record
This audit distinguishes completed source review from fields that have not yet been researched.
This submission was added after the prior exact-submission extraction and remains queued for source review. Exact FDA identity, indication, modality, anatomy, workflow, and limitations were reviewed using the submission as the identity anchor. Current vendor material is product-family context only. PubMed and ClinicalTrials.gov candidates remain quarantined as product-family evidence because exact submission and version linkage was not established. CMS and openFDA index context was checked. Pricing, security, deployment, reimbursement, contracted services, enabled options, and local interoperability remain unknown unless separately evidenced. Automated exact-name discovery found 0 PubMed and 0 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads remain unpublished until a human confirms the exact product and tested version.
Source classes: fda ai list, fda decision summary, vendor product page, implementation documentation, reimbursement policy, peer reviewed literature, clinical trial registry, fda device recall, pubmed, clinical trials, openfda device recall
Sources
Sources accessed through 2026-09-04.
Alternatives
Canon Medical Systems Corporation
Vantage Fortian and Orian 1.5T produce diagnostic MR images of the head and body, including labeled noncontrast angiography, for trained technologists and physician interpretation.
Ge Medical Systems, LLC
AIR Recon DL adds a deep-learning phase-correction and reconstruction option to supported GE 1.5T, 3T, and 7T MR workflows for all labeled anatomies and ages to reduce noise or...
Siemens Healthcare GmbH
The listed MAGNETOM 1.5T and 3T MRI systems produce cross-sectional images, spectroscopic images or spectra, and derived physical parameters of the head, body, and extremities for...
Siemens Shenzhen Magnetic Resonance, Ltd.
MAGNETOM Free.Max and Free.Star with syngo MR XA80A are 0.55T MRI systems for broad imaging and compatible interventions; this release adds dentomaxillofacial coil and assist...